CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Drug Response
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Drug Response: A Secondary Analyses of the KARISMA Trial
Ann. Oncol 2021 Jul 17;[EPub Ahead of Print], W He, M Eriksson, E Eliasson, F Grassmann, M Bäcklund, M Gabrielson, M Hammarström, S Margolin, L Thorén, Y Wengström, S Borgquist, P Hall, K CzeneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.